FDA updates labeling for FLOWTUSS
Labeling changes approved for CHARTWELL RX. Active ingredient: GUAIFENESIN; HYDROCODONE BITARTRATE. Decision date: 12/22/2025
Labeling changes approved for CHARTWELL RX. Active ingredient: GUAIFENESIN; HYDROCODONE BITARTRATE. Decision date: 12/22/2025
There are no comments here yet...